Brief: Pegbio Co Enters MoU With Rani Therapeutics
10/07/2026 02:25
BRIEF-Pegbio Co Enters MoU With Rani Therapeutics July 10 (Reuters) - PegBio Co Ltd 2565.HK:
ENTERS MOU WITH NASDAQ-LISTED RANI THERAPEUTICS
COLLABORATION TO ADVANCE ORAL DELIVERY OF MULTIPLE METABOLIC ASSETS
Further company coverage: 2565.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition